GlycoMimetics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-35.84-31.16-12.75-15.07
Price/Sales ratio
312.27878.47150.7722.46
Earnings per Share (EPS)
$-0.45$-0.51$-1.26$-1.07

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-11.94-8.51-4.07-14.82-8.05-4.22-3.41-1.17-1.70-4.05-0.00-8.05
Price/Sales ratio
8.845.417.20KN/AN/AN/A16.9163.872.12K14.94K0.95N/A
Price/Book Value ratio
2.612.683.674.121.891.481.340.903.703.890.001.48
Price/Cash Flow ratio
-31.02-13.19-4.36-16.57-8.97-4.40-4.38-1.28-3.42-4.28-0.00-8.97
Price/Free Cash Flow ratio
-29.56-12.77-4.26-16.41-8.94-4.38-4.37-1.28-3.41-4.28-0.00-8.94
Price/Earnings Growth ratio
0.12-0.72-0.030.60-1.81-0.710.28-0.09-0.030.06-0.01-1.81
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%N/AN/AN/A100%12.61%-1277.58%100%99.90%N/A
Operating Profit Margin
-74.13%-63.69%-177300%N/AN/AN/A-506.82%-5469.56%-63267.26%-392752.93%-37376.84%N/A
Pretax Profit Margin
-74.01%-63.61%-176722.22%N/AN/AN/A-502.08%-5467.84%-62312.97%-368994.2%-48544.77%N/A
Net Profit Margin
-74.01%-63.61%-176722.22%N/AN/AN/A-494.67%-5443.31%-124562.69%-368994.2%-48544.05%N/A
Effective Tax Rate
1.42%1.49%0.59%N/A-6.69%6.52%1.47%0.44%-99.89%0.00%N/A-6.69%
Return on Assets
-19.42%-26.34%-75.04%-25.88%-22.46%-32.21%-35.19%-66.92%-180.13%-81.42%-70.34%-32.21%
Return On Equity
-21.89%-31.55%-90.11%-27.80%-23.49%-35.09%-39.20%-77.37%-217.39%-96.05%-67.86%-35.09%
Return on Capital Employed
-21.92%-31.39%-88.51%-28.18%-24.99%-39.09%-39.49%-76.88%-110.41%-102.06%-65.36%-39.09%
Liquidity Ratios
Current Ratio
8.686.096.3915.5624.2214.8411.12N/AN/AN/A5.7114.84
Quick Ratio
8.686.046.3615.5624.22409.54110.6652.775.726.405.39409.54
Cash ratio
8.546.046.3215.1523.9514.4411.027.635.396.115.3914.44
Days of Sales Outstanding
0.540.705.44KN/AN/AN/A0.070.42701.576.41KN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A-0.53-1.75MN/A-192.21K-51.06N/AN/A-0.53
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A-192.21K650.51N/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A3.66K3.53K582.69N/A758.92343.08N/AN/A582.69
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-192.97K307.42N/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.17N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.20N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-83.45N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.121.191.201.071.041.081.111.151.201.171.201.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.28-0.41-1.65KN/AN/AN/A-3.86-49.55-620.05-3.48K-399.27N/A
Free Cash Flow / Operating Cash Flow Ratio
1.041.031.021.001.001.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-32.63N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A